published by Damascus University
in 2009
in Medicine
and research's language is
العربية
Download
Abstract in English
Osteoarthritis (OA) is a frequent cause of joint pain and is
estimated to be the most common cause of disability in adults. The goals of
management of patients with osteoarthritis (OA) are to control pain and
swelling, minimize disability, improve the quality of life, and educate the
patient about his or her role in the management team. The effects of
intraarticular hyaluronans in OA have been the subject of several studies.
Their aim has been to determine whether intraarticular supplementation of
these macromolecules, which are deficient in degenerative cartilage, can
lead to decreased symptoms of osteoarthritis.
References used
Vejc K, Hyllested JL, Ostergaard K. Osteoarthritis, pathogenesis, clinical features and treatment. Vgeskr Laegev. 2002 Jun 10; 164(24):3173-9
Kirwan, JR, Elson, CJ. Is the progression of osteoarthritis phasic? Evidence and implications. J Rheumatol 2000; 27:834
Van Dijk GM; Dekker J; Veenhof C; van den Ende CH .Course of functional status and pain in osteoarthritis of the hip or knee: A systematic review of the literature. Arthritis Rheum. 2006 Sep 29; 55(5):779-785